ERAS insider transaction filings

Erasca, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-12. Screen ERAS transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 7 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Bristol James Arthur — Director11
Casdin Alexander W. — Director11
Fuchs Charles S. — President, R&D11
Hambleton Julie — Director11
LIU JEAN I — Director11
Multani Pratik S — Director11
Start Valerie Denise Harding — Director11

Recent Form 4 filings — Erasca, Inc.

FiledFormInsiderReported transactionsSource
2026-08-124Fuchs Charles S. — President, R&DGrant/award (A): 1,300,000 (derivative) @ $0EDGAR
2026-06-294Bristol James Arthur — DirectorGrant/award (A): 29,888 (derivative) @ $0EDGAR
2026-06-294Start Valerie Denise Harding — DirectorGrant/award (A): 29,888 (derivative) @ $0EDGAR
2026-06-294Multani Pratik S — DirectorGrant/award (A): 29,888 (derivative) @ $0EDGAR
2026-06-294Hambleton Julie — DirectorGrant/award (A): 29,888 (derivative) @ $0EDGAR
2026-06-294Casdin Alexander W. — DirectorGrant/award (A): 29,888 (derivative) @ $0EDGAR
2026-06-294LIU JEAN I — DirectorGrant/award (A): 29,888 (derivative) @ $0EDGAR
2026-04-034Garner Ebun — Chief Legal OfficerOption exercise (M): 80,000 @ $1.70 · Sale (S): 80,000 @ $16.40 · Option exercise (M): 80,000 (derivative) @ $0EDGAR
2026-03-064Morris Shannon — Chief Medical OfficerOption exercise (M): 20,000 @ $1.70 · Sale (S): 20,000 @ $15.04 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2026-01-304Chacko David M. — CFO and CBOOther (J): 17,793 @ $1.19 · Grant/award (A): 640,000 (derivative) @ $0EDGAR
2026-01-304Morris Shannon — Chief Medical OfficerGrant/award (A): 625,000 (derivative) @ $0EDGAR
2026-01-304Varney Michael David — DirectorGrant/award (A): 96,000 (derivative) @ $0EDGAR
2026-01-304Garner Ebun — General Counsel & Corp. Sec.Grant/award (A): 560,000 (derivative) @ $0EDGAR
2026-01-304Lim Jonathan E — Chairman & CEO, Director, 10% ownerGrant/award (A): 2,000,000 (derivative) @ $0EDGAR
2026-01-084Garner Ebun — General Counsel & Corp. Sec.Grant/award (A): 3,902 @ $1.19 · Option exercise (M): 120,000 @ $1.70 · Sale (S): 120,000 @ $5.59 · Option exercise (M): 120,000 (derivative) @ $0EDGAR
2026-01-054Bristol James Arthur — DirectorGrant/award (A): 37,762 (derivative) @ $0EDGAR
2026-01-054Start Valerie Denise Harding — DirectorGrant/award (A): 24,306 (derivative) @ $0EDGAR
2026-01-054Multani Pratik S — DirectorGrant/award (A): 19,532 (derivative) @ $0EDGAR
2026-01-054Casdin Alexander W. — DirectorGrant/award (A): 23,872 (derivative) @ $0EDGAR
2026-01-054LIU JEAN I — DirectorGrant/award (A): 20,617 (derivative) @ $0EDGAR
2025-06-264Bristol James Arthur — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2025-06-264Start Valerie Denise Harding — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2025-06-264Varney Michael David — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2025-06-264Multani Pratik S — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2025-06-264Hambleton Julie — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2025-06-264Casdin Alexander W. — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2025-06-264LIU JEAN I — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2025-06-034Multani Pratik S — DirectorGift (G): 6,200 @ $0 · Gift (G): 6,200 @ $0EDGAR
2025-02-184Garner Ebun — General Counsel & Corp. Sec.Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-02-054Chacko David M. — CFO and CBOOther (J): 3,137 @ $1.56 · Other (J): 12,324 @ $1.56 · Grant/award (A): 800,000 (derivative) @ $0EDGAR
2025-02-054Morris Shannon — Chief Medical OfficerGrant/award (A): 780,000 (derivative) @ $0EDGAR
2025-02-054Garner Ebun — General Counsel & Corp. Sec.Other (J): 5,715 @ $1.56 · Other (J): 5,731 @ $1.56 · Grant/award (A): 700,000 (derivative) @ $0EDGAR
2025-02-054Lim Jonathan E — Chairman & CEO, Director, 10% ownerGrant/award (A): 2,500,000 (derivative) @ $0EDGAR
2025-01-024Bristol James Arthur — DirectorGrant/award (A): 45,678 (derivative) @ $0EDGAR
2025-01-024Start Valerie Denise Harding — DirectorGrant/award (A): 29,402 (derivative) @ $0EDGAR
2025-01-024Casdin Alexander W. — DirectorGrant/award (A): 28,877 (derivative) @ $0EDGAR
2025-01-024LIU JEAN I — DirectorGrant/award (A): 24,939 (derivative) @ $0EDGAR
2024-06-214Morris Shannon — Chief Medical OfficerGrant/award (A): 137,142 (derivative) @ $0EDGAR
2024-06-214Chacko David M. — CFO and CBOGrant/award (A): 278,812 (derivative) @ $0EDGAR
2024-06-214Bristol James Arthur — DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR
2024-06-214Start Valerie Denise Harding — DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR
2024-06-214Varney Michael David — DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR
2024-06-214Multani Pratik S — DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR
2024-06-214Hambleton Julie — DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR
2024-06-214Casdin Alexander W. — DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR
2024-06-214Garner Ebun — General Counsel & Corp. Sec.Grant/award (A): 160,082 (derivative) @ $0EDGAR
2024-06-214Lim Jonathan E — Chairman & CEO, Director, 10% ownerGrant/award (A): 632,759 (derivative) @ $0EDGAR
2024-06-214LIU JEAN I — DirectorGrant/award (A): 60,000 (derivative) @ $0EDGAR
2024-05-224Casdin Alexander W. — DirectorPurchase (P): 80,000 @ $2.27EDGAR
2024-02-074Lim Jonathan E — Chairman & CEO, Director, 10% ownerGrant/award (A): 1,500,000 (derivative) @ $0EDGAR

Recent 8-K events — Erasca, Inc.

FiledFormItems reportedSource
2026-08-248-K8.01 — Other EventsEDGAR
2026-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-108-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-07-148-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-138-K8.01 — Other EventsEDGAR
2026-07-018-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-278-K7.01 — Regulation FD Disclosure
8.01 — Other Events
EDGAR
2026-04-278-K8.01 — Other EventsEDGAR
2026-04-218-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ERAS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →